Uterine morphology in normogonadotropic anovulation: a comparative study of polycystic ovary syndrome and hypothalamic-pituitary-ovarian dysfunction - Top-Institutions - MDSpire

Uterine morphology in normogonadotropic anovulation: a comparative study of polycystic ovary syndrome and hypothalamic-pituitary-ovarian dysfunction

  • By

  • Iwona Gawron

  • Karolina Zeman

  • Justyna Brodowicz

  • Robert Jach

  • April 2, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Reproductive Endocrinology
    • Gynecology
    • Ultrasonography

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Reproductive Endocrinology
    • Gynecologic Imaging
    • Endocrinology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Reproductive Endocrinology
    • Gynecology
    • Ultrasound Imaging

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Reproductive Endocrinology
    • Gynecology
    • Ultrasonography

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gynecology
    • Reproductive Endocrinology
    • Medical Imaging

Original Source(s)

Uterine morphology in normogonadotropic anovulation: a comparative study of polycystic ovary syndrome and hypothalamic-pituitary-ovarian dysfunction

  • by Iwona Gawron, Karolina Zeman, Justyna Brodowicz, Robert Jach

  • April 2, 2026

Related Content

Global, regional and national burden of polycystic ovary syndrome: historical trends from 1990 to 2021 and projections to 2035

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome

Non-linear saturation threshold of gonadotropin dose on cumulative live birth rates in advanced-age women with polycystic ovary syndrome: a retrospective cohort study